Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis
Mairead K. Heavey, Anthony Hazelton, Yuyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

Nano-engineered probiotic treats atherosclerosis via inhibiting intestinal microbiota-TMA-TMAO axis
Boxuan Ma, Zhezhe Chen, Qiongjun Zhu, et al.
Research Square (Research Square) (2025)
Closed Access
Delivering living medicines with biomaterials
Tetsuhiro Harimoto, Wei‐Hung Jung, David Mooney
Nature Reviews Materials (2025)
Closed Access
Inflammation-Targeted Delivery of Probiotics for Alleviation of Colitis and Associated Cognitive Disorders through Improved Vitality and Colonization
Yi Chen, Mingju Shui, Hongyi Li, et al.
Biomaterials (2025) Vol. 318, pp. 123163-123163
Closed Access
Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease
Haichen Wang, Feifei Zhou, Mengdan Shen, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1383-1399
Open Access
Dental problems and oral microbiome alterations in ulcerative colitis
Robert Kucharski, Bartosz Kamil Sobocki, Ewa Stachowska, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Development of a Dihydrofolate Reductase Selection System for Saccharomyces boulardii
Hua Yu, Lydia K. Nyasae, Rachel Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2073-2073
Open Access
Saccharomyces boulardii Alleviates Colitis by Regulating FXR-NLRP3 Mediated Macrophage Pyroptosis
Lijiao Yang, Wanyu Li, Qianjing Zhao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3161-3176
Open Access
Multifunctional Double-Loaded Oral Nanoplatform for Computed Tomography Imaging-Guided and Integrated Treatment of Inflammatory Bowel Disease
Yaoting He, Ziyang Jin, Yifan Wang, et al.
ACS Nano (2025)
Closed Access
Probiotic Saccharomyces boulardii Against Cronobacter sakazakii Infection: In Vitro and In Vivo Studies
Samaneh Allahyari, Babak Pakbin, Shaghayegh Pishkhan Dibazar, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Engineering Saccharomyces boulardii for enhanced surface display capacity
Luping Xu, Xingjian Bai, Deokyeol Jeong, et al.
Microbial Cell Factories (2025) Vol. 24, Iss. 1
Open Access
Engineered Probiotic Saccharomyces boulardii Reduces Colitis-Associated Colorectal Cancer Burden in Mice
Tyler Culpepper, Krithika Senthil, Jiřı́ Vlček, et al.
Digestive Diseases and Sciences (2025)
Closed Access
Engineering advanced bacterial therapy for tumor and inflammatory diseases
Yuanyuan Chen, Qiuju Han
International Journal of Pharmaceutics (2025), pp. 125585-125585
Closed Access
A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden
Olivia N. Rebeck, Miranda J. Wallace, Jerome Prusa, et al.
Cell chemical biology (2024)
Open Access | Times Cited: 4
Effects of Saccharomyces boulardii cell wall polysaccharide on growth performance, immunity, antioxidant ability and ileal mucosal morphology of Jinhua weaned piglets in Northern Xinjiang region
Weiyun Zhu, Xucheng Mo, Weimin Zeng, et al.
Frontiers in Animal Science (2025) Vol. 6
Open Access
Iota-carrageenan oligosaccharide ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating SCFAs-PI3K-AKT pathway
Meixian Xiang, Songtao Wu, M. Liu, et al.
Inflammopharmacology (2025)
Closed Access
Novel selenium-enriched Pichia kudriavzevii as a dietary supplement to alleviate dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota and host metabolism
Huijuan Wang, Yue Chen, Zhouli Wang, et al.
Food & Function (2024) Vol. 15, Iss. 21, pp. 10698-10716
Closed Access | Times Cited: 3
Advancements in emulsion systems for specialized infant formulas: Research process and formulation proposals for optimizing bioavailability of nutraceuticals
Liling Zhang, Yang Hu, Ling Jiang
Comprehensive Reviews in Food Science and Food Safety (2024) Vol. 23, Iss. 6
Open Access | Times Cited: 3
From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel disease
Yuewen Huang, Peng Shan, Rong Zeng, et al.
Microbiological Research (2024) Vol. 289, pp. 127928-127928
Closed Access | Times Cited: 2
The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases
Walaa K. Mousa, A. Ali
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11259-11259
Open Access | Times Cited: 2
Surface-Functionalized Bacteria: Frontier Explorations in Next-Generation Live Biotherapeutics
Jianqing Jiang, Fanhui Kong, Qi Lei, et al.
Biomaterials (2024) Vol. 317, pp. 123029-123029
Closed Access | Times Cited: 2
Advances in the research of intestinal fungi in Crohn's disease
Mo-Wei Kong, Yu Yang, Peng Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4318-4323
Closed Access | Times Cited: 1
Yeast probiotic Saccharomycopsis fibuligera alleviates the colorectal cancer by inhibiting the choline metabolism
Xinyang Li, Chenxu Wang, Xinyue Wang, et al.
Research Square (Research Square) (2024)
Open Access
Controlled release of microorganisms from engineered living materials
Manivannan Sivaperuman Kalairaj, Iris George, Sasha M. George, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Rewiring Tryptophan Metabolism via Programmable Probiotic Integrated by Dual-Layered Microcapsule Protects against Inflammatory Bowel Disease in Mice
Wen Li, Yichen Liu, Xiaoming Zheng, et al.
ACS Nano (2024) Vol. 18, Iss. 52, pp. 35443-35464
Closed Access
Orally surface engineered probiotic system for ulcerative colitis therapy via modulating gut microbiota and immune homeostasis
Junyu Liu, Zhihao Fang, Xiaopeng Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top